ZBH Zimmer Biomet Holdings, Inc.

Price (delayed)

$139.66

Market cap

$28.92B

P/E Ratio

698.3

Dividend/share

$0.96

EPS

$0.2

Enterprise value

$36.41B

Sector: Healthcare
Industry: Medical Devices
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Highlights

The debt has declined by 15% since the previous quarter and by 6% year-on-year
The EPS has soared by 111% YoY but it has plunged by 89% from the previous quarter
The net income has surged by 110% year-on-year but it has dropped by 90% since the previous quarter
Zimmer Biomet Holdings's gross profit has decreased by 11% YoY and by 11% from the previous quarter
The revenue has contracted by 11% YoY and by 10% from the previous quarter

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
207.05M
Market cap
$28.92B
Enterprise value
$36.41B
Valuations
Price to earnings (P/E)
698.3
Price to book (P/B)
2.48
Price to sales (P/S)
4.11
EV/EBIT
N/A
EV/EBITDA
37.28
EV/Sales
5.18
Earnings
Revenue
$7.03B
EBIT
-$37.3M
EBITDA
$976.8M
Free cash flow
$899.3M
Per share
EPS
$0.2
Free cash flow per share
$4.35
Book value per share
$56.29
Revenue per share
$33.98
TBVPS
$37.37
Balance sheet
Total assets
$23.65B
Total liabilities
$12B
Debt
$8.21B
Equity
$11.64B
Working capital
$2.55B
Liquidity
Debt to equity
0.71
Current ratio
2.18
Quick ratio
0.82
Net debt/EBITDA
7.67
Margins
EBITDA margin
13.9%
Gross margin
71.1%
Net margin
0.5%
Operating margin
-0.6%
Efficiency
Return on assets
0.1%
Return on equity
0.3%
Return on invested capital
-0.3%
Return on capital employed
-0.2%
Return on sales
-0.5%
Dividend
Dividend yield
0.69%
DPS
$0.96
Payout ratio
480%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.03B
Gross profit
$5B
Operating income
-$45.1M
Net income
$36.7M
Gross margin
71.1%
Net margin
0.5%
Zimmer Biomet Holdings's operating margin has shrunk by 200% YoY and by 114% QoQ
Zimmer Biomet Holdings's operating income has shrunk by 114% QoQ
The net margin has surged by 111% year-on-year but it has dropped by 90% since the previous quarter
The net income has surged by 110% year-on-year but it has dropped by 90% since the previous quarter

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
P/E
698.3
P/B
2.48
P/S
4.11
EV/EBIT
N/A
EV/EBITDA
37.28
EV/Sales
5.18
The EPS has soared by 111% YoY but it has plunged by 89% from the previous quarter
The stock's P/B is 13% above its 5-year quarterly average of 2.2 and 13% above its last 4 quarters average of 2.2
ZBH's price to sales (P/S) is 28% higher than its 5-year quarterly average of 3.2 and 21% higher than its last 4 quarters average of 3.4
The revenue has contracted by 11% YoY and by 10% from the previous quarter

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROS has plunged by 112% from the previous quarter and by 67% YoY
The ROIC has shrunk by 111% QoQ and by 50% YoY
Zimmer Biomet Holdings's return on equity has surged by 110% YoY but it has shrunk by 90% QoQ
The ROA has soared by 107% YoY but it has plunged by 93% from the previous quarter

Dividends

What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.69%
Payout ratio
480%
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 97% higher than the total liabilities
The current ratio has soared by 83% YoY and by 29% from the previous quarter
ZBH's quick ratio has soared by 82% YoY but it is down by 11% QoQ
The debt is 29% smaller than the equity
The debt has declined by 15% since the previous quarter and by 6% year-on-year
The debt to equity has declined by 12% since the previous quarter and by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.